Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.48 |
| ▸ | CTSD | P07339 | 1/20 | 0.46 |
| ▸ | JAK2 | O60674 | 3/20 | 0.44 |
| ▸ | TYK2 | P29597 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | RAD52 | P43351 | 1/20 | 0.41 |
| ▸ | NT5E | P21589 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | JAK1 | P23458 | 2/20 | 0.40 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.40 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.40 |
| ▸ | MPO | P05164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14241685 | 0.86 | FDPS (0.50) | FDPSKDM4EL3MBTL1MDM2CTSD | |
| SCHEMBL14241687 | 0.80 | KMT2A (0.52) | FDPSKDM4EL3MBTL1MDM2CTSD | |
| SCHEMBL17319265 | 0.77 | FDPS (0.43) | FDPSKDM4EL3MBTL1MDM2CTSD | |
| SCHEMBL195068 | 0.75 | CA9 (0.52) | FDPSKDM4ECTSDALDH1A1HTT | |
| SCHEMBL4743946 | 0.74 | FDPS (0.61) | FDPSKDM4EALDH1A1KMT2APOLB | |
| SCHEMBL9328080 | 0.73 | CA9 (0.50) | FDPSKDM4EHTT | |
| SCHEMBL915097 | 0.71 | MMP2 (0.46) | KDM4EL3MBTL1ALDH1A1KMT2APOLB | |
| SCHEMBL2693735 | 0.71 | MMP2 (0.55) | KDM4EL3MBTL1GAAALDH1A1KMT2A | |
| SCHEMBL14241212 | 0.71 | FDPS (0.65) | FDPSKDM4EL3MBTL1MDM2CTSD | |
| SCHEMBL7790457 | 0.71 | CA12 (0.64) | FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080039490-A1 | PYRIDINES FOR TREATING INJURED MAMMALIAN NERVE TISSUE | PURDUE RESEARCH FOUNDATION (US) | 2008-02-14 | — | — | US | claimed |
| EP-1567497-A4 | PYRIDINES FOR TREATING INJURED MAMMALIAN NERVE TISSUE | PURDUE RESEARCH FOUNDATION (US) | 2006-11-15 | — | — | EP | claimed |
| EP-1567497-A2 | PYRIDINES FOR TREATING INJURED MAMMALIAN NERVE TISSUE | Purdue Research Foundation (US) | 2005-08-31 | — | — | EP | claimed |
| US-20040171587-A1 | Pyridines for treating injured mammalian nerve tissue | PURDUE RESEARCH FOUNDATION | 2004-09-02 | — | — | US | claimed |
| WO-2004052291-A2 | PYRIDINES FOR TREATING INJURED MAMMALIAN NERVE TISSUE | PURDUE RESEARCH FOUNDATION (US) | 2004-06-24 | — | — | WO | claimed |
| US-20170313920-A1 | Biological Buffers with Wide Buffering Ranges | DALY THOMAS P (US) | 2017-11-02 | — | — | US | disclosed |
| US-20170260435-A1 | Biological Buffers with Wide Buffering Ranges | DALY THOMAS P (US) | 2017-09-14 | — | — | US | disclosed |
| US-20160369142-A1 | Biological Buffers with Wide Buffering Ranges | DALY THOMAS P (US) | 2016-12-22 | — | — | US | disclosed |
| US-9475754-B2 | Biological buffers with wide buffering ranges | TPAT IP LLC | 2016-10-25 | — | — | US | disclosed |
| US-20160280634-A1 | Biological Buffers with Wide Buffering Ranges | TPAT IP LLC | 2016-09-29 | — | — | US | disclosed |
| US-9447310-B2 | Biological buffers with wide buffering ranges | TPAT IP LLC | 2016-09-20 | — | — | US | disclosed |
| US-20160194283-A1 | Biological Buffers with Wide Buffering Ranges | TPAT IP LLC | 2016-07-07 | — | — | US | disclosed |
| US-20110130429-A1 | PYRIDINES FOR TREATING INJURED MAMMALIAN NERVE TISSUE | PURDUE RESEARCH FOUNDATION (US) | 2011-06-02 | — | — | US | disclosed |
| EP-1567497-B1 | PYRIDINES FOR TREATING INJURED MAMMALIAN NERVE TISSUE | PURDUE RESEARCH FOUNDATION (US) | 2009-09-23 | — | — | EP | disclosed |
| US-20080039490-A1 | PYRIDINES FOR TREATING INJURED MAMMALIAN NERVE TISSUE | PURDUE RESEARCH FOUNDATION (US) | 2008-02-14 | — | — | US | disclosed |
| US-7244748-B2 | Pyridines for treating injured mammalian nerve tissue | PURDUE RESEARCH FOUNDATION (US) | 2007-07-17 | — | — | US | disclosed |
| EP-1567497-A4 | PYRIDINES FOR TREATING INJURED MAMMALIAN NERVE TISSUE | PURDUE RESEARCH FOUNDATION (US) | 2006-11-15 | — | — | EP | disclosed |
| EP-1567497-A2 | PYRIDINES FOR TREATING INJURED MAMMALIAN NERVE TISSUE | Purdue Research Foundation (US) | 2005-08-31 | — | — | EP | disclosed |
| US-20040171587-A1 | Pyridines for treating injured mammalian nerve tissue | PURDUE RESEARCH FOUNDATION | 2004-09-02 | — | — | US | disclosed |
| WO-2004052291-A2 | PYRIDINES FOR TREATING INJURED MAMMALIAN NERVE TISSUE | PURDUE RESEARCH FOUNDATION (US) | 2004-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170260435-A1 | Biological Buffers with Wide Buffering Ranges | PEF1, SLC7A1, PLPBP | FDPS 4531/4885KDM4E 2858/4885L3MBTL1 3471/4885 |
| US-20160280634-A1 | Biological Buffers with Wide Buffering Ranges | PEF1, SLC7A1, PLPBP | FDPS 4531/4885KDM4E 2858/4885L3MBTL1 3471/4885 |
| US-20040171587-A1 | Pyridines for treating injured mammalian nerve tissue | P2RY4, INA, P2RY1 | FDPS 1385/4885KDM4E 74/4885L3MBTL1 2182/4885 |
| US-20160194283-A1 | Biological Buffers with Wide Buffering Ranges | PEF1, SLC7A1, PLPBP | FDPS 4531/4885KDM4E 2858/4885L3MBTL1 3471/4885 |
| US-20160369142-A1 | Biological Buffers with Wide Buffering Ranges | PEF1, SLC7A1, PLPBP | FDPS 4531/4885KDM4E 2858/4885L3MBTL1 3471/4885 |
| US-20080039490-A1 | PYRIDINES FOR TREATING INJURED MAMMALIAN NERVE TISSUE | P2RY4, INA, PMP22 | FDPS 1371/4885KDM4E 74/4885L3MBTL1 2216/4885 |
| US-20170313920-A1 | Biological Buffers with Wide Buffering Ranges | PEF1, SLC7A1, PLPBP | FDPS 4531/4885KDM4E 2858/4885L3MBTL1 3471/4885 |
| US-20110130429-A1 | PYRIDINES FOR TREATING INJURED MAMMALIAN NERVE TISSUE | PMP22, SMN1; SMN2, MUSK | FDPS 3170/4885KDM4E 107/4885L3MBTL1 1186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.